Prostanoid receptors involved in the relaxation of human pulmonary vessels
- 1 February 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (4) , 859-866
- https://doi.org/10.1038/sj.bjp.0702393
Abstract
1. To characterize the prostanoid receptors on human pulmonary smooth muscle involved in vasodilatations, isolated arteries and veins were contracted with norepinephrine (10 microM) and vessels were subsequently challenged with different prostanoid-receptor agonists in the absence or presence of selective antagonists. 2. Prostaglandin D2 (PGD2) and the selective DP-receptor agonist, BW245C, induced relaxations in the contracted human pulmonary venous preparations. The pD2 values were: 6.88+/-0.11 (n=17) and 7.31+/-0.12 (n=5), respectively. The relaxant responses induced by PGD2 were reduced by the selective DP-receptor antagonist, BWA868C, and the estimated pA2 value was 7.84+/-0.16 (n=4). PGD2 and BW245C did not relax contracted human pulmonary arteries. 3. The selective IP-receptor agonists, iloprost and cicaprost, both induced relaxations in the contracted human vascular preparations. The pD2 values for iloprost were: 7.84+/-0.08 (n=6) and 8.25+/-0.06 (n=4) and for cicaprost: 8.06+/-0.12 (n=5) and 8.11+/-0.09 (n=5) in arteries and veins respectively. 4. Prostaglandin E2 (PGE2) and the EP2/EP3-receptor agonist, misoprostol, partially relaxed the contracted venous preparations and the pD2 values were: 8.10+/-0.15 (n=15) and 6.24+/-0.33 (n=3), respectively. These relaxations suggest the presence of an EP receptor in the human pulmonary veins. The contracted human pulmonary arteries did not relax when challenged with PGE2. 5. In human pulmonary venous preparations, the PGE2-induced relaxations were neither modified by treatment with TP/EP4-receptor antagonist, AH23848B (10 and 30 microM, n=6), nor by the DP/EP1/EP2-receptor antagonist, AH6809 (3 microM, n=6). 6. These data suggest that the relaxation induced by prostanoids involved DP-, IP-receptors and to a lesser extent an EP-receptor on human pulmonary venous smooth muscle. In contrast, only the IP-receptor is involved in the prostanoid induced relaxations on human pulmonary arterial smooth muscle.Keywords
This publication has 42 references indexed in Scilit:
- Prostanoid receptors involved in the relaxation of human bronchial preparationsBritish Journal of Pharmacology, 1999
- Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generationBritish Journal of Pharmacology, 1997
- Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous veinProstaglandins, 1996
- 6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonistBiochemical Pharmacology, 1995
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.Circulation, 1994
- Endothelium dependence of prostanoid‐induced relaxation in human hand veinsActa Physiologica Scandinavica, 1994
- A novel inhibitory prostanoid receptor in piglet saphenous veinProstaglandins, 1994
- Cloning and Expression of the EP2 Subtype of Human Receptors for Prostaglandin E2Biochemical and Biophysical Research Communications, 1993
- Prostaglandin Receptors Coupled to Adenylyl Cyclase in the Iris-Ciliary Body of Rabbits, Cats and CowsExperimental Eye Research, 1993